INMED PHARMACEUTICALS INC

Historical 13F Holders

Symbol
INM
CUSIP
457637502
All holders as of
Q2 2022
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 457637502 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Sabby Management, LLC 13G/A
4.9% 1/3/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2022 Q2 19 1.10 M $515 k
2022 Q1 21 363 k $342 k
2021 Q4 19 410 k $536 k
2021 Q3 20 560 k $981 k
2021 Q2 21 945 k $2.99 M
2021 Q1 23 467 k $1.55 M
2020 Q4 17 42.1 k $138 k